Cargando…

Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P‐Glycoprotein (P‐gp) and Breast Cancer Resistance Protein (BCRP)

The transmembrane ABC transporters P‐glycoprotein (P‐gp) and breast cancer resistance protein (BCRP) are widely recognized for their role in cancer multidrug resistance and absorption and distribution of compounds. Furthermore, they are linked to drug–drug interactions and toxicity. Nevertheless, du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarz, Theresa, Montanari, Floriane, Cseke, Anna, Wlcek, Katrin, Visvader, Lene, Palme, Sarah, Chiba, Peter, Kuchler, Karl, Urban, Ernst, Ecker, Gerhard F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949556/ https://www.ncbi.nlm.nih.gov/pubmed/26970257 http://dx.doi.org/10.1002/cmdc.201500592

Ejemplares similares

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors
por: Montanari, Floriane, et al.
Publicado: (2016)

Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
por: Montanari, Floriane, et al.
Publicado: (2016)

Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators
por: Dei, Silvia, et al.
Publicado: (2019)

ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
por: Brzozowska, Natalia, et al.
Publicado: (2016)

Exhaustive Sampling of Docking Poses Reveals Binding Hypotheses for Propafenone Type Inhibitors of P-Glycoprotein
por: Klepsch, Freya, et al.
Publicado: (2011)

Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
por: Feinshtein, Valeria, et al.
Publicado: (2013)

Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents
por: Lee, Jaeok, et al.
Publicado: (2021)

Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
por: Gameiro, Mariline, et al.
Publicado: (2017)

Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy
por: Szatmári, Péter, et al.
Publicado: (2023)

Allicin affects the pharmacokinetics of sulfadiazine and florfenicol by downregulating the expression of jejunum P-gp and BCRP in broilers
por: Wang, Xiaoming, et al.
Publicado: (2022)

Prediction of drug–ABC-transporter interaction — Recent advances and future challenges☆
por: Montanari, Floriane, et al.
Publicado: (2015)

Structural definition of polyspecific compensatory ligand recognition by P-glycoprotein
por: Le, Christina A., et al.
Publicado: (2020)

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Propafenone and propranolol dual toxicity
por: Farooq, Moonis, et al.
Publicado: (2020)

Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein
por: Xia, Di, et al.
Publicado: (2019)

Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition
por: Saib, Sonia, et al.
Publicado: (2021)

Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice
por: Hernández-Lozano, Irene, et al.
Publicado: (2021)

Proarrhythmia Induced by Propafenone: What is the Mechanism?
por: Femenia, Francisco, et al.
Publicado: (2010)

Characterization of murine polyspecific monoamine transporters
por: Miura, Yamato, et al.
Publicado: (2017)

OCT1 Polyspecificity—Friend or Foe?
por: Meyer, Marleen J., et al.
Publicado: (2021)

Reassessing the Safety of Pill-in-the-Pocket Propafenone
por: Kim, Andrew G, et al.
Publicado: (2023)

A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models
por: Boumendjel, Ahcene, et al.
Publicado: (2009)

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib
por: Dufour, Robin, et al.
Publicado: (2015)

Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5
por: Sachs, Julia, et al.
Publicado: (2019)

Effect of enzalutamide on PK of P‐gp and BCRP substrates in cancer patients: CYP450 induction may not always predict overall effect on transporters
por: Poondru, Srinivasu, et al.
Publicado: (2022)

Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
por: Noguchi, Kohji, et al.
Publicado: (2014)

Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity
Publicado: (1986)

Propafenone Overdose: From Cardiogenic Shock to Brugada Pattern
por: Gil, Julio, et al.
Publicado: (2018)

Subtle features in the performance of P8603/S
por: Thomsen, B
Publicado: (1990)

Unambiguous Assignment of the (1)H- and (13)C-NMR Spectra of Propafenone and a Thiophene Analogue
por: Holzer, Wolfgang
Publicado: (2001)

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids
Publicado: (1981)

Human Germline Antibody Gene Segments Encode Polyspecific Antibodies
por: Willis, Jordan R., et al.
Publicado: (2013)

Propafenone Hepatotoxicity: Report of a New Case and Review of the Literature
por: Younan, Lara B., et al.
Publicado: (2013)

Propafenone is not effective for severe ventricular arrhythmias in Andersen-Tawil syndrome
por: Bienias, Piotr, et al.
Publicado: (2016)

A simple mathematical approach to the analysis of polypharmacology and polyspecificity data
por: Maggiora, Gerry, et al.
Publicado: (2017)

Evaluation of IgY Antibody as a Polyspecific Coombs-Reagent
por: Calzado, Esteban Justo Gutiérrez, et al.
Publicado: (2017)

Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P‐gp and BCRP
por: Ou, Ying C., et al.
Publicado: (2021)

Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse
por: Kummer, Wolfgang, et al.
Publicado: (2006)

Structural basis for polyspecificity in the POT family of proton-coupled oligopeptide transporters
por: Lyons, Joseph A, et al.
Publicado: (2014)

Pharmacokinetics of propafenone hydrochloride sustained-release capsules in male beagle dogs
por: Pan, Liping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_34nu173nphvp47184tmoj8tv1k